218 related articles for article (PubMed ID: 35000608)
21. Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601.
Sugawara S; Maemondo M; Tachihara M; Inoue A; Ishimoto O; Sakakibara T; Usui K; Watanabe H; Matsubara N; Watanabe K; Kanazawa K; Ishida T; Saijo Y; Nukiwa T;
Lung Cancer; 2013 Jul; 81(1):91-6. PubMed ID: 23643176
[TBL] [Abstract][Full Text] [Related]
22. A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer.
Schuette WH; Gröschel A; Sebastian M; Andreas S; Müller T; Schneller F; Guetz S; Eschbach C; Bohnet S; Leschinger MI; Reck M
Clin Lung Cancer; 2013 May; 14(3):215-23. PubMed ID: 23332288
[TBL] [Abstract][Full Text] [Related]
23. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group.
Costa Rivas M; Huidobro Vence G; Fírvida Pérez JL; Campos Balea B; García Gonzalez J; Lázaro Quintela M; Caeiro Muñoz M; Taboada Valladares B; Castro Gómez JE; Vázquez Estevez S; Afonso Afonso FJ; Azpitarte Raposeiras C; Amenedo Gancedo M; Casal Rubio J
Clin Transl Oncol; 2018 Nov; 20(11):1467-1473. PubMed ID: 29696478
[TBL] [Abstract][Full Text] [Related]
24. Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.
Rossi A; Chiodini P; Sun JM; O'Brien ME; von Plessen C; Barata F; Park K; Popat S; Bergman B; Parente B; Gallo C; Gridelli C; Perrone F; Di Maio M
Lancet Oncol; 2014 Oct; 15(11):1254-62. PubMed ID: 25232001
[TBL] [Abstract][Full Text] [Related]
25. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
Rossi A; Di Maio M; Chiodini P; Rudd RM; Okamoto H; Skarlos DV; Früh M; Qian W; Tamura T; Samantas E; Shibata T; Perrone F; Gallo C; Gridelli C; Martelli O; Lee SM
J Clin Oncol; 2012 May; 30(14):1692-8. PubMed ID: 22473169
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials.
Scagliotti GV; Gridelli C; de Marinis F; Thomas M; Dediu M; Pujol JL; Manegold C; San Antonio B; Peterson PM; John W; Chouaki N; Visseren-Grul C; Paz-Ares LG
Lung Cancer; 2014 Sep; 85(3):408-14. PubMed ID: 25088661
[TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy and safety for different chemotherapy regimens used concurrently with thoracic radiation for locally advanced non-small cell lung cancer: a systematic review and network meta-analysis.
Liu T; He Z; Dang J; Li G
Radiat Oncol; 2019 Mar; 14(1):55. PubMed ID: 30925881
[TBL] [Abstract][Full Text] [Related]
28. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
Chen YM; Perng RP; Shih JF; Tsai CM; Whang-Peng J
Lung Cancer; 2007 Jun; 56(3):363-9. PubMed ID: 17306906
[TBL] [Abstract][Full Text] [Related]
29. Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.
Tan EH; Rolski J; Grodzki T; Schneider CP; Gatzemeier U; Zatloukal P; Aitini E; Carteni G; Riska H; Tsai YH; Abratt R
Ann Oncol; 2009 Jul; 20(7):1249-56. PubMed ID: 19276396
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer.
Akdeniz N; Küçüköner M; Kaplan MA; Urakçı Z; Karhan O; Sezgin Y; Bilen E; Ebinç S; Teke F; Laçin Ş; Alan Ö; Ercelep Ö; Işıkdoğan A; Yumuk PF
Int J Clin Oncol; 2020 Dec; 25(12):2015-2024. PubMed ID: 32797321
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis.
Griesinger F; Korol EE; Kayaniyil S; Varol N; Ebner T; Goring SM
Lung Cancer; 2019 Sep; 135():196-204. PubMed ID: 31446995
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, placebo-controlled study of B-cell lymphoma 2 homology 3 mimetic gossypol combined with docetaxel and cisplatin for advanced non-small cell lung cancer with high expression of apurinic/apyrimidinic endonuclease 1.
Wang Y; Li X; Zhang L; Li M; Dai N; Luo H; Shan J; Yang X; Xu M; Feng Y; Xu C; Qian C; Wang D
Invest New Drugs; 2020 Dec; 38(6):1862-1871. PubMed ID: 32529467
[TBL] [Abstract][Full Text] [Related]
33. Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
Bennouna J; Havel L; Krzakowski M; Kollmeier J; Gervais R; Dansin E; Serke M; Favaretto A; Szczesna A; Cobo M; Ciuffreda L; Jassem J; Nicolini M; Ramlau R; Amoroso D; Melotti B; Almodovar T; Riggi M; Caux NR; Vaissière N; Tan EH
Clin Lung Cancer; 2014 Jul; 15(4):258-65. PubMed ID: 24954228
[TBL] [Abstract][Full Text] [Related]
34. Elderly subset analysis of randomized phase III study comparing pemetrexed plus carboplatin with docetaxel plus carboplatin as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer.
Pereira JR; Cheng R; Orlando M; Kim JH; Barraclough H
Drugs R D; 2013 Dec; 13(4):289-96. PubMed ID: 24277116
[TBL] [Abstract][Full Text] [Related]
35. Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06).
Locher C; Pourel N; Le Caer H; Berard H; Auliac JB; Monnet I; Descourt R; Vergnenègre A; Lafay IM; Greillier L; Chouaïd C
Lung Cancer; 2018 Jul; 121():25-29. PubMed ID: 29858022
[TBL] [Abstract][Full Text] [Related]
36. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non-small cell lung cancer: A meta-analysis of randomized controlled trials.
Liu M; Luo N; Fang Z; Liu Q; Yi F; Wei Y; Zhang X; Zhang W
J Clin Pharm Ther; 2022 Feb; 47(2):157-167. PubMed ID: 34617297
[TBL] [Abstract][Full Text] [Related]
39. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Brown T; Pilkington G; Bagust A; Boland A; Oyee J; Tudur-Smith C; Blundell M; Lai M; Martin Saborido C; Greenhalgh J; Dundar Y; Dickson R
Health Technol Assess; 2013 Jul; 17(31):1-278. PubMed ID: 23886301
[TBL] [Abstract][Full Text] [Related]
40. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
Pignon JP; Tribodet H; Scagliotti GV; Douillard JY; Shepherd FA; Stephens RJ; Dunant A; Torri V; Rosell R; Seymour L; Spiro SG; Rolland E; Fossati R; Aubert D; Ding K; Waller D; Le Chevalier T;
J Clin Oncol; 2008 Jul; 26(21):3552-9. PubMed ID: 18506026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]